Modified plant-derived exosomes: Precision medicine in cancer treatment

Abstract

Plant-derived exosomes (PDEs) are extracellular vesicles (EVs) occurring naturally, which have propitious applications in the development of cost-effective and fruitful cancer therapy with minimum aftereffects and ramifications. Recent advancements in research based on PDEs demonstrate their extraordinary advantages in cancer therapy. The components of PDEs exhibit accomplished cancer prevention activity and having insignificant or negligible toxicity. The conventional methods to deliver drugs to the target have various problems, several of which can be solved by using PDEs for drug delivery. The main constituents of PDEs are proteins, lipids, DNA and RNA. PDEs are believed to revolutionize cancer therapy due to their magnificent attributes, but only a few clinical trials on PDEs are in progress. The mechanisms and regulations by which PDEs execute anticancer properties are yet not completely understood. Hence, research are conducted worldwide to understand the mechanisms of action of cancer antagonist PDEs more comprehensively and perspicuously. Modified PDEs have prospect in evolution of precision medicine which can bring a new dimension in the treatment of cancer.

Keywords

cancer therapy / mammalian derived exosome / membrane transporters / nanomedicine / plant derived exosome

References

[1] Yi Q, Xu Z, Thakur A, Zhang K, Liang Q, Liu Y, et al. Current understanding of plant-derived exosome-like nanoparticles in regulating the inflammatory response and immune system microenvironment. Pharmacol Res. 2023;190:106733.

[2] Madhan S, Dhar R, Devi A. Plant-derived exosomes: a green approach for cancer drug delivery. J Mater Chem. 2024;12(9):2236-2252.

[3] Di Bella MA. Overview and update on extracellular vesicles: considerations on exosomes and their application in modern medicine. Biology. 2022;11(6):804.

[4] Dhar R, Mukerjee N, Mukherjee D, Devi A, Jha SK, Gorai S. Plant-derived exosomes: a new dimension in cancer therapy. Phytother Res. 2024;38(4):1721-1723.

[5] Jin Z, Na J, Lin X, Jiao R, Liu X, Huang Y. Plant-derived exosome-like nanovesicles: a novel nanotool for disease therapy. Heliyon. 2024;10(9):e30630.

[6] Corvigno S, Liu Y, Bayraktar E, et al. Enhanced plant-derived vesicles for nucleotide delivery for cancer therapy. npj Precis Onc. 2024;86:8.

RIGHTS & PERMISSIONS

2024 2024 The Author(s). Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.